Syncom Formul.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE312C01025
  • NSEID: SYNCOMF
  • BSEID: 524470
INR
14.29
0.41 (2.95%)
BSENSE

Jun 12, 03:30 PM

BSE+NSE Vol: 16.1 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Fredun Pharma
Lincoln Pharma.
Amrutanjan Healt
Ind-Swift Labs.
Syncom Formul.
Jagsonpal Pharma
Beta Drugs Ltd
Shukra Pharma.
Bajaj Healthcare
Fermenta Biotec.
Accent Microcell

Why is Syncom Formulations (India) Ltd ?

1
Poor long term growth as Net Sales has grown by an annual rate of -64.25% and Operating profit at -50.07% over the last 5 years
2
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
3
Underperformed the market in the last 1 year
  • Even though the market (BSE500) generated negative returns of -2.24% in the last 1 year, its fall in the stock was much higher with a return of -34.60%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Syncom Formul. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Syncom Formul.
-34.6%
-0.95
36.59%
Sensex
-7.55%
-0.58
13.06%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-64.25%
EBIT Growth (5y)
-50.07%
EBIT to Interest (avg)
31.65
Debt to EBITDA (avg)
0.72
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
9.88
Tax Ratio
24.42%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.22%
ROCE (avg)
80.28%
ROE (avg)
119.22%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
18
Industry P/E
34
Price to Book Value
3.24
EV to EBIT
17.37
EV to EBITDA
15.91
EV to Capital Employed
4.06
EV to Sales
2.52
PEG Ratio
0.32
Dividend Yield
NA
ROCE (Latest)
23.35%
ROE (Latest)
18.41%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
PAT(Q)

At Rs 25.17 cr has Grown at 46.1% (vs previous 4Q average

PBDIT(Q)

Highest at Rs 22.01 cr.

EPS(Q)

Highest at Rs 0.27

-1What is not working for the Company
NON-OPERATING INCOME(Q)

is 43.18 % of Profit Before Tax (PBT

Loading Valuation Snapshot...

Here's what is working for Syncom Formul.

Profit After Tax (PAT) - Quarterly
At Rs 25.17 cr has Grown at 46.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 17.23 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 22.01 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 25.17 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 0.27
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Syncom Formul.

Non Operating Income - Quarterly
is 43.18 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Non Operating Income - Quarterly
Highest at Rs 14.55 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income